Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Procept Biorobotics Corp

PRCT ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Small Cap Analyst: HOLD

Last Close

$21.60

▲ +1.65%

Market Cap $1.24B · Vol 235.87K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$1.24B

Small Cap

Div Yield

N/A

EPS Growth

+2.92%

YoY

RSI (14)

60.78

Momentum

Beta

0.90

vs Market

52W High

$42.43

49.09% below

52W Low

$16.67

29.57% above

Volume

235.87K

Avg 584.62K

P/B

4.84

Price-to-book

ROE

-24.89%

Return on equity

Free Float

96.71%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Procept Biorobotics Corp (PRCT) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PRCT pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.31%

+29.42%

-25.52%

-22.41%

YTD

-31.34%

-45.05%

-30.05%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$308.05M
Net Income	$-95,572,000.00
Revenue Growth (YoY)	+19.34%
Gross Margin	63.70%
Operating Margin	-33.71%
Net Profit Margin	-31.02%
ROE	-24.89%
ROA · ROIC	-18.31% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	5.67
P/B	4.84
P/FCF	N/A
EPS Growth	+2.92%
Outstanding Shares	57.27M

Technical Indicators

50-Day SMA	$20.41
200-Day SMA	$26.38
RSI (14)	60.78
Beta	0.90
52-Week High	$42.43
52-Week Low	$16.67

Volume Today	235.87K
Avg Daily Volume (30D)	584.62K
Relative Volume	0.40x
Volatility (10D)	58.57
Volatility (30D)	55.14
Free Float	96.71%

Analyst Consensus

HOLD

Current Price $21.60

Mean Target $24.23

52W Low$16.67 52W High$42.43

Current

Target

$16.67 $42.43

Current Analyst target

+12.18% upside potential · 15 analysts

Identifiers

ExchangeNasdaq

FIGIBBG009KD84J2

ISINUS74276L1052

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateNov 2, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.46% MDT Medtronic PLC -1.89% COR Cencora Inc +1.33% 7741.T Hoya Corp +0.40% BDX Becton Dickinson and Co -0.50%

Company Profile

PROCEPT BioRobotics Corporation is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are advanced, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). It designed Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that is independent of prostate size and shape and delivers resection independent of surgeon experience. It manufactures the robotic systems, the single-use disposable handpiece, integrated scope and other accessories at its facility in San Jose, California. Each robotic system is shipped to its customers with a third-party manufactured ultrasound system and probe.